These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8628414)

  • 41. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test.
    Nakama H; Fattah AS; Zhang B; Kamijo N; Uehara Y
    Hepatogastroenterology; 2000; 47(35):1277-9. PubMed ID: 11100332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT.
    Allison JE
    Gastroenterology; 2005 Aug; 129(2):745-8. PubMed ID: 16083728
    [No Abstract]   [Full Text] [Related]  

  • 44. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
    Nakama H; Zhang B; Kamijo N
    Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fecal analysis for occult blood obsolete].
    Otten MH; Rodenburg CJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(10):573-4. PubMed ID: 8628415
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fecal analysis for occult blood obsolete].
    Swinkels DW; Wollersheim H; Willems JL
    Ned Tijdschr Geneeskd; 1996 Mar; 140(10):572; author reply 573. PubMed ID: 8628413
    [No Abstract]   [Full Text] [Related]  

  • 48. Unusual lubricants do not interfere with the Hemoccult test for occult blood.
    Totten VY; Ference A; Siladji E
    Acad Emerg Med; 1997 Oct; 4(10):1007-8. PubMed ID: 9332636
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fecal analysis for occult blood obsolete].
    Rubens M
    Ned Tijdschr Geneeskd; 1996 Mar; 140(10):572-3. PubMed ID: 8628414
    [No Abstract]   [Full Text] [Related]  

  • 51. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sensitivity, specificity and predictive value in laboratory tests].
    Takagi Y; Gomi K
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():5-10. PubMed ID: 9097554
    [No Abstract]   [Full Text] [Related]  

  • 54. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.